Frank-ter Haar syndrome is a rare genetic condition that affects bones, eyes, and facial development. Many people with Frank-ter Haar syndrome have wide-set eyes, vision problems, joint stiffness, and distinctive facial features, and doctors may also see heart or skeletal differences on exam or imaging. Signs are present from infancy and last lifelong, though the exact mix and severity can vary. Care focuses on supportive therapies like eye care, physical therapy, heart and bone monitoring, and surgery when needed. The outlook depends on which organs are involved, and some complications can be serious, so regular specialist follow-up is important.
Overview
Frank-ter haar syndromeSymptoms
Early signs of Frank-ter Haar syndrome include prominent eyes, a wide soft spot, distinctive facial shape, loose joints, and bowed or short bones affecting movement. Babies may also have glaucoma, hernias, heart problems, and later developmental delays.
Outlook and prognosis
Many people with Frank-ter Haar syndrome face early-onset bone changes, distinctive facial features, and eye problems that can affect vision and growth. Care focuses on comfort, vision protection, and mobility, with coordinated support from eye, bone, dental, and heart specialists. Prognosis varies by severity; regular monitoring helps anticipate complications and plan supportive treatments.
Causes and risk factors
Frank-ter Haar syndrome results from harmful changes in a single gene and is inherited in an autosomal recessive pattern. Risk increases when both parents are carriers; consanguinity raises carrier likelihood. No proven environmental or lifestyle causes are known.
Genetic influences
Genetics is central in Frank-ter Haar syndrome; it’s caused by inherited changes in the SH3PXD2B gene. Most cases follow an autosomal recessive pattern, so both parents are usually carriers. Genetic testing confirms diagnosis and guides family planning and counseling.
Diagnosis
Doctors suspect Frank-ter Haar syndrome from a pattern of facial, eye, and bone features seen on exam and imaging. Genetic diagnosis of Frank-ter Haar syndrome is confirmed by finding a disease-causing change in the SH3PXD2B gene through molecular testing.
Treatment and drugs
Frank-ter Haar syndrome care focuses on comfort, protecting vision and joints, and supporting breathing and growth. Treatment often includes eye surgery or glasses, orthopedic care, physical therapy, and tailored nutrition. A genetics team coordinates specialists and long‑term follow‑up.
Symptoms
Frank-ter Haar syndrome affects how bones, eyes, and some organs form before birth. Parents often notice early features of Frank-ter Haar syndrome in the first months, such as prominent eyes or a wide soft spot on the head. Features vary from person to person and can change over time. Many will need ongoing eye checks and heart monitoring as they grow.
Prominent eyes are common in Frank-ter Haar syndrome because the eye sockets can be shallow. This can cause dryness or irritation and make bright light uncomfortable.
In Frank-ter Haar syndrome, high pressure inside the eye from birth can cloud the cornea and blur vision. It often leads to tearing, light sensitivity, and an enlarged-looking eye.
The soft spot on the top of the head (fontanel) can be wider and stay open longer. Helmets or hats may fit differently, and doctors monitor head shape and growth over time.
Frank-ter Haar syndrome affects how bones form in the skull, chest, spine, and limbs. This can change posture, flexibility, and movement.
How people usually first notice Frank-ter haar syndrome?
Families often notice something unusual in the first weeks to months of life, such as prominent eyes that don’t close fully, a small chin, or a flat midface, sometimes paired with feeding difficulties or poor weight gain. Doctors may first suspect Frank-ter Haar syndrome after seeing these facial traits together with broad thumbs or big toes, stiff joints, or early heart or eye findings on exam or ultrasound, prompting genetic testing to confirm the diagnosis. For many, the “first signs of Frank-ter Haar syndrome” are this combination of distinctive facial features and early skeletal or eye concerns that lead clinicians to look closer.
Types of Frank-ter haar syndrome
Frank-ter Haar syndrome is a rare genetic condition present from birth, with features that can affect bone growth, eye development, facial structure, and the heart and blood vessels. Clinicians often describe them in these categories: people with a more classic, multisystem form and those with milder or atypical presentations. Because data are limited, no formal subtypes are universally agreed upon, but experts recognize a spectrum of severity rather than distinct types of Frank-ter Haar syndrome. If you’re looking for types of Frank-ter Haar syndrome, think of them as clinical variants based on how many body systems are involved and how strongly they’re affected.
Classic multisystem form
Features often appear in infancy, with prominent eye findings, distinctive facial shape, and bone differences. Heart or blood vessel issues and delayed growth may be present. Early specialist care across ophthalmology, cardiology, and orthopedics is often needed.
Milder/attenuated form
Core features are present but tend to be fewer or less severe across systems. Vision or skeletal differences may be milder, and heart findings may be absent or limited. Daily functioning can be closer to typical with focused monitoring.
Atypical/variant presentations
Some people show an uneven pattern—strong skeletal changes but milder eye issues, or the reverse. Others have features that partially overlap the classic picture without meeting every hallmark. Not everyone will experience every type.
What genetics can tell you about symptoms
Some people with Frank-ter Haar syndrome develop wide-set eyes, a small chin, joint laxity, fragile bones, and heart or eye problems because pathogenic SH3PXD2B variants disrupt proteins that help cells build and remodel connective tissues. When this “scaffolding” is weak, bones, joints, heart valves, and eye structures don’t form or hold up as expected.
Causes and risk factors
Frank-ter Haar syndrome happens when a child inherits two nonworking copies of the SH3PXD2B gene. Parents who each carry one changed copy have a 25% chance in each pregnancy of having a child with the condition. This carrier pairing is more likely when parents are related by blood, such as cousins. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Lifestyle or exposures do not cause Frank-ter Haar syndrome, but they may influence how severe some features are, and carrier screening and genetic counseling can clarify risk factors for Frank-ter Haar syndrome in a family.
Environmental and biological risk factors
Research to date has not identified clear environmental risk factors for Frank-ter Haar syndrome. Doctors often group risks into internal (biological) and external (environmental). For this condition, the drivers appear to be body-based and present before birth, while specific outside exposures have not been confirmed.
Biological differences that lead to this syndrome begin early in fetal development. This points to body-based risks present before birth rather than outside triggers.
No clear link between advanced maternal or paternal age and the likelihood of Frank-ter Haar syndrome has been shown. Current reports do not suggest an age-related effect.
Specific pregnancy conditions such as high blood pressure or diabetes have not been tied to a higher chance of this syndrome occurring. Available data have not shown a consistent pattern.
Infections during pregnancy have not been shown to cause Frank-ter Haar syndrome. Case descriptions do not reveal a consistent infection-related pattern.
Genetic risk factors
Changes in a gene called SH3PXD2B drive this rare condition, Frank-ter Haar syndrome. Some risk factors are inherited through our genes. The condition usually follows an autosomal recessive pattern, meaning two non-working copies are needed. Knowing the genetic cause can help families recognize early symptoms of Frank-ter Haar syndrome and plan care.
SH3PXD2B variants: Changes in the SH3PXD2B gene are the known cause of Frank-ter Haar syndrome. These changes disrupt normal development of bones, eyes, and connective tissues.
Autosomal recessive: A child is affected when they inherit two non-working copies of SH3PXD2B, one from each parent. Parents who carry one changed copy usually have no symptoms.
Carrier parents: When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of Frank-ter Haar syndrome. There is also a 50% chance the child will be a healthy carrier and a 25% chance to inherit no variants.
Family history: Having an affected sibling raises the chance that other children in the same family could be affected. Genetic counseling can provide tailored recurrence risk numbers.
Parental relatedness: When parents are related by blood, such as cousins, they are more likely to carry the same rare variant. This increases the chance of a child inheriting both non-working copies.
Genetic testing: Testing the SH3PXD2B gene can confirm Frank-ter Haar syndrome in an affected person and identify carrier relatives. Results can guide testing in future pregnancies, including options like prenatal or preimplantation testing.
Lifestyle risk factors
Lifestyle choices do not cause Frank-ter Haar syndrome, but they can shape daily function, symptoms, and the risk of complications. Understanding how lifestyle affects Frank-ter Haar syndrome helps families focus on changes with the most impact. The elements below link habits to specific outcomes for joints, bones, eyes, breathing, and mobility. Work with your care team to tailor these to individual abilities and needs.
Regular gentle exercise (e.g., swimming or cycling) can strengthen muscles that stabilize lax joints and support posture. High-impact or contact sports may raise risks of joint dislocation and pain.
Using supportive footwear, avoiding extreme ranges of motion, and pacing repetitive tasks can reduce micro-injuries to unstable joints. Overstretching or heavy lifting may worsen joint laxity and recovery time.
Adequate protein, calcium, and vitamin D intake helps maintain bone mineralization in the setting of skeletal fragility. Poor intake increases fracture risk and slows rehabilitation after injuries.
Keeping weight in a personalized healthy range lessens mechanical stress on lax joints and the spine. Excess weight can worsen pain, limit mobility, and increase breathing strain.
Risk prevention
Because Frank-ter Haar syndrome is inherited, the condition itself can’t be prevented after conception, but families can plan ahead and people living with it can lower the risk of complications. Some prevention is universal, others are tailored to people with specific risks. Early symptoms of Frank-ter Haar syndrome can be subtle, so spotting issues early and staying on a regular monitoring schedule makes a real difference. Planning care with experienced specialists helps protect heart, eye, breathing, and bone health over time.
Genetic counseling can clarify carrier status and the chance of passing on Frank-ter Haar syndrome. Options may include carrier testing for partners, prenatal testing, or IVF with embryo testing.
If there’s a family history or suggestive findings on ultrasound, ask about targeted genetic testing. A confirmed diagnosis early on allows timely checks for heart, eye, breathing, and bone concerns.
Scheduled visits with cardiology, ophthalmology, orthopedics, and respiratory care help catch problems before they escalate. Prevention works best when combined with regular check-ups.
Echocardiograms and blood pressure checks can detect heart or vessel issues linked to Frank-ter Haar syndrome. Treating concerns early lowers the risk of complications later.
Transmission
Frank-ter Haar syndrome is not contagious; it cannot be caught or spread between people. It is inherited in an autosomal recessive way, meaning a child must receive one nonworking copy of the same gene from each parent, who typically have no symptoms. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with Frank-ter Haar syndrome, a 50% (1 in 2) chance of a child who is a carrier like the parents, and a 25% (1 in 4) chance of a child who is neither affected nor a carrier. This is the usual genetic transmission of Frank-ter Haar syndrome, and genetic counseling and carrier testing can help families understand how Frank-ter Haar syndrome is inherited.
When to test your genes
Frank-ter Haar syndrome is a rare, genetic condition; consider genetic testing when a baby shows early skeletal, eye, or facial differences, or when there’s a family history of similar findings or infant loss. Testing helps confirm the diagnosis, guide specialist care, and clarify recurrence risks for future pregnancies. Parents and at-risk relatives can discuss carrier or prenatal testing with a genetics professional.
Diagnosis
Frank-ter Haar syndrome is usually recognized in infancy based on a pattern of physical features and health findings that tend to occur together. Early and accurate diagnosis can help you plan ahead with confidence. Doctors then confirm the clinical picture with targeted tests to understand which organs are involved and to guide care.
Doctors look for a consistent combination of facial differences, prominent eyes, joint laxity, and bone changes seen from birth or early infancy. Growth patterns and overall development are reviewed to see how features fit together.
A pediatric eye exam checks for large corneas, high eye pressure, or vision issues that can appear early. Pressure measurements and careful inspection of the front of the eye help confirm eye involvement.
X-rays of the skull, spine, ribs, hands, and long bones look for characteristic bone patterns. These may include thin or under-mineralized bones and specific skull changes that support the diagnosis.
An echocardiogram and ECG evaluate the heart’s structure and rhythm. These tests look for valve or structural differences that can occur with this syndrome and help plan monitoring.
Stages of Frank-ter haar syndrome
Frank-ter Haar syndrome does not have defined progression stages. It’s a genetic condition present from birth, and while features can change as a child grows, the pattern varies widely and isn’t grouped into standard stages. Diagnosis is usually based on early symptoms of Frank-ter Haar syndrome, a detailed physical exam, eye and heart evaluations, and imaging such as X‑rays; Genetic testing may be offered to clarify certain risks. Ongoing care often involves regular check-ins with eye and heart specialists and orthopedic teams to track things like eye pressure, heart function, and bone development over time.
Outlook and prognosis
Looking at the long-term picture can be helpful. Frank-ter Haar syndrome often affects several body systems from early life, so daily life usually involves regular visits with eye, heart, bone, and dental specialists. Many people ask, “What does this mean for my future?”, and the honest answer is that the outlook varies based on which organs are involved and how severe those changes are. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
For some children with Frank-ter Haar syndrome, early symptoms include eye issues like high pressure in the eye, changes to the cornea, and vision loss; others may face heart valve or vessel problems that need close monitoring. Severe heart or lung complications can be life‑limiting, and in the medical literature, early mortality has been reported, especially when major cardiovascular issues are present. At the same time, there are individuals who reach adolescence or adulthood, particularly when eye pressure is managed, breathing is supported as needed, and the heart is stable. The future may look uncertain now, but coordinated care with cardiology, ophthalmology, orthopedics, dentistry, and rehabilitation can improve comfort, function, and safety.
Understanding the prognosis can guide planning and help families set realistic goals over time. With ongoing care, many people maintain the best vision possible, protect joint function, and lower the risk of complications from high eye pressure or heart strain. Talk with your doctor about what your personal outlook might look like, including how your child’s current heart and eye findings influence risk. Genetic testing can sometimes provide more insight into prognosis, and not everyone with the same gene change will have the same outlook.
Long-term effects
Frank-ter Haar syndrome can have long-term effects that mainly involve vision, bone strength, joints, and growth. While early symptoms of Frank-ter Haar syndrome often involve the eyes and bones, the long-term picture centers on vision and musculoskeletal health. Long-term effects vary widely, and they can change with age. Some features may stay stable for years, while others can slowly progress.
Congenital glaucoma can keep eye pressure high and damage the optic nerve. This may lead to partial vision loss over time. Severe cases can progress to legal blindness.
Reduced bone strength can raise the chance of fractures. Breaks may occur after relatively minor trauma. This risk can persist from childhood into adulthood in Frank-ter Haar syndrome.
Loose joints can cause instability and uneven joint loading. For many, this can mean early cartilage wear and osteoarthritis. Stiffness and decreased range of motion may develop with age.
Scoliosis or kyphosis may appear in later childhood. Curvature can worsen during growth spurts. In more pronounced cases, chest shape and posture can be affected.
How is it to live with Frank-ter haar syndrome?
Life with Frank-ter Haar syndrome often means navigating complex medical needs from early childhood, with frequent visits to specialists for eyes, bones, heart, and growth. Daily routines may include vision supports, mobility aids, physical and occupational therapy, and careful monitoring for breathing or feeding difficulties, while school and home environments are adapted to maximize comfort, learning, and independence. Families and caregivers become skilled coordinators, balancing appointments and equipment with moments of play, connection, and rest, and many find support groups and care teams invaluable for guidance and encouragement. Friends, teachers, and relatives usually play a meaningful role too, learning how to help with access, communication, and safety so the child can participate as fully as possible.
Treatment and drugs
Frank-ter Haar syndrome is managed by focusing on symptoms and day-to-day function, since there’s no single cure for the condition. Care is usually coordinated by a team—often including pediatrics, genetics, orthopedics, cardiology, eye specialists, dentistry/craniofacial surgery, physiotherapy, and nutrition—to address bone differences, joint stiffness, vision problems, dental and facial features, breathing issues, and possible heart involvement. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as pain relief for joints, glaucoma drops or eye surgery when needed, antibiotics for recurrent infections, and careful monitoring of the heart and lungs; surgeries may help with severe skeletal or craniofacial concerns and airway support. Supportive care can make a real difference in how you feel day to day, with physical and occupational therapy to maintain mobility, feeding and growth support, and early developmental services. Not every treatment works the same way for every person, so plans are reviewed regularly to adjust as children grow and needs change.
Non-drug treatment
For many living with Frank-ter Haar syndrome, the most helpful care focuses on practical supports that make daily life safer and more comfortable. Non-drug treatments often lay the foundation for mobility, vision, breathing, feeding, and learning. Understanding early symptoms of Frank-ter Haar syndrome can guide timely referrals to the right specialists and therapies. Care plans are usually tailored, and they may change as children grow or as needs shift over time.
A team-based plan brings orthopedics, eye care, cardiology, dentistry, therapy services, and genetics together. This helps align appointments and priorities so care feels less overwhelming.
Gentle strengthening and balance work can protect joints and improve movement. Programs are adapted to joint laxity and bone differences to reduce pain and falls.
Hand and daily-living skills training can make dressing, writing, and play easier. Therapists may suggest tools and strategies to protect loose joints during routine tasks.
Braces, splints, or custom insoles can stabilize flexible joints and improve alignment. These devices may also reduce fatigue and support safer walking.
Your genes may have an impact on how drugs work for you
Medicines for Frank-ter Haar syndrome are limited and mostly supportive, and how a person responds can vary because genes affect drug processing and sensitivity. Pharmacogenetic testing, when available, may guide dosing or drug choice to improve safety and benefit.
Pharmacological treatments
People living with Frank-ter Haar syndrome may need medicines to ease day-to-day issues like high eye pressure, heart strain, or musculoskeletal pain that can limit play, school, and sleep. Drugs that target symptoms directly are called symptomatic treatments. Plans are tailored to the person’s age and findings, and medicines may be started when early symptoms of Frank-ter Haar syndrome, such as raised eye pressure, are found. Because features vary, teams revisit benefits and side effects over time to keep treatment on track.
Timolol, latanoprost, dorzolamide, brinzolamide, and brimonidine can lower eye pressure and protect vision. These may be used alone or in combination if pressure stays high. Some medicines work quickly, while others may take a few weeks for full effect.
Acetazolamide by mouth may be used short term if eye pressure is very high or before surgery. It can cause tingling in fingers, frequent urination, or stomach upset, so monitoring is important. Ask your doctor why a specific drug was recommended for you.
Enalapril or captopril (ACE inhibitors) and diuretics like furosemide can reduce heart strain if valve problems or heart failure features are present. Spironolactone may be added to help control fluid and protect the heart. Doctors adjust treatment plans regularly to match growth and changing needs.
Acetaminophen or ibuprofen can help with joint or bone pain from skeletal differences. Take with food and follow dosing guidance, especially if there are heart, kidney, or stomach concerns. Never stop or change a prescription without checking with your healthcare provider.
Genetic influences
Frank-ter Haar syndrome is most often linked to changes in a single gene called SH3PXD2B, which helps cells shape and move as the body develops. The condition follows a recessive pattern: a child typically needs two changed copies of the gene—one from each parent—to be affected. A “carrier” means you hold the gene change but may not show symptoms. If both parents are carriers, each pregnancy has a 1 in 4 (25%) chance of an affected child, a 1 in 2 (50%) chance of a carrier child, and a 1 in 4 (25%) chance of a child with neither change. Genetic testing for Frank-ter Haar syndrome can look for SH3PXD2B changes to confirm the diagnosis, and testing parents or siblings can clarify who carries the gene change. Severity can vary between individuals, even in the same family, so genetic counseling can help interpret results and discuss options for future pregnancies.
Is Frank-ter haar syndrome genetic?
Genetics is central in Frank-ter Haar syndrome; it’s caused by inherited changes in the SH3PXD2B gene. Most cases follow an autosomal recessive pattern, so both parents are usually carriers. Genetic testing confirms diagnosis and guides family planning and counseling.
Pharmacogenetics—how genetics influence drug effects
Care for Frank-ter Haar syndrome often involves eye pressure treatment, orthopedic procedures, and heart monitoring, so medicines may be used at different stages of life. Alongside medical history and other health factors, genetic testing may help guide safer drug and dose choices. The gene change that causes Frank-ter Haar syndrome isn’t known to directly change how the body processes medicines, so most drug decisions follow general pharmacogenetics rather than syndrome‑specific rules. For example, some people convert codeine to its active form very slowly and get little pain relief after surgery, while others convert it faster and may have stronger side effects; in those cases, doctors may choose a different pain reliever or adjust the dose. If heart medicines, blood thinners, or glaucoma eye drops are part of your plan, your team may consider potential drug–gene interactions, monitor your heart rate, blood pressure, or eye pressure more closely, and personalize the regimen. It’s reasonable to ask whether pharmacogenetic testing in Frank-ter Haar syndrome could add value for you, especially if past medicines didn’t work well or caused unexpected side effects.
Interactions with other conditions
Because Frank-ter haar syndrome can affect the eyes, skeleton, and sometimes the heart, other health issues may interact with it in practical ways. Doctors call it a “comorbidity” when two conditions occur together. If glaucoma is part of the early symptoms of Frank-ter haar syndrome, steroid medicines (including eye drops, pills, and some inhalers) can raise eye pressure, so treatment plans usually avoid or closely monitor these drugs. When congenital heart differences are present, common respiratory infections or planned surgeries and anesthesia may pose higher risks, and teams often coordinate cardiology, anesthesia, and respiratory care ahead of time. Bone and joint features can also overlap with low vitamin D or reduced mobility; addressing those can lower fracture risk and support growth. Vision changes may compound learning or developmental needs from other causes, so combining ophthalmology care with early therapy and education support can make day-to-day life easier.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described infants with strikingly large eyes, soft skull bones, and feeding challenges, long before Frank-ter Haar syndrome had a name. Families recalled newborns who needed extra support with breathing or feeding, while doctors noted unusually flexible joints and differences in facial shape. In many places, these stories stayed local, passed quietly within communities, and the condition was often grouped with other bone or connective tissue disorders because the features overlapped.
First described in the medical literature as a cluster of findings in the late 20th century, Frank-ter Haar syndrome was initially recognized through careful bedside observation and X‑rays. Specialists saw a pattern: changes in skull and facial bones, broad ribs, joint laxity, and eye findings that appeared together in early life. From these first observations, clinicians began to draw connections among scattered case reports, realizing they were seeing the same condition in different families.
As medical science evolved, detailed imaging and standardized clinical checklists sharpened the picture. Pediatricians and geneticists compared notes, distinguishing Frank-ter Haar syndrome from look‑alike conditions such as other forms of skeletal dysplasia. Over time, descriptions became more consistent: early symptoms of Frank-ter Haar syndrome could include prominent eyes, difficulties with feeding or breathing, and joint looseness, while doctors documented characteristic bone changes on scans.
Advances in genetics later confirmed what families and clinicians suspected—a shared biological cause linking these features. Researchers identified changes in a specific gene involved in building and maintaining connective tissues, which helped explain the combination of bone, joint, and eye findings. This genetic insight clarified inheritance, showing why the condition could appear in siblings while parents had no symptoms.
In recent decades, knowledge has built on a long tradition of observation. Larger registries and international collaboration brought together cases from different countries, expanding understanding of how varied Frank-ter Haar syndrome can be. Some children have more prominent bone findings, while others show more eye or cardiovascular features; recognizing this range has helped doctors make earlier, more accurate diagnoses.
Today, the history of Frank-ter Haar syndrome reflects a steady path from bedside clues to genetic proof. Knowing the condition’s history helps explain why older records sometimes used different names, and why some people were misclassified in the past. It also highlights how family stories, careful clinical work, and modern genetics came together to define a rare condition more clearly, guiding better care and support for those living with it.